-Oncolytics Biotech Announces Clinical and Biomarker Data Demonstrating Clinical Proof-of-Concept for Pelareorep-Checkpoint Inhibitor Combination in Pancreatic Cancer

  • Bin Zhang

Press/Media: Press / Media

PeriodMay 21 2021

Media coverage

1

Media coverage

  • Title-Oncolytics Biotech Announces Clinical and Biomarker Data Demonstrating Clinical Proof-of-Concept for Pelareorep-Checkpoint Inhibitor Combination in Pancreatic Cancer
    Media name/outletENP Newswire
    Country/TerritoryUnited Kingdom
    Date05/21/21
    PersonsBin Zhang